• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Digirad signs distribution deal with NIR

Article

Digital gamma camera developer Digirad of San Diego announced this month that it has signed a distribution and service agreement with National Imaging Resources for its Digirad 2020 TC Imager. Birmingham, AL-based NIR will gain U.S. distribution rights

Digital gamma camera developer Digirad of San Diego announced this month that it has signed a distribution and service agreement with National Imaging Resources for its Digirad 2020 TC Imager. Birmingham, AL-based NIR will gain U.S. distribution rights to the system, which uses solid-state detectors made from cadmium zinc telluride.

The agreement gives Digirad access to a strong sales structure it has not had before: NIR boasts 190 sales representatives, a 400-member service organization, and a regional network consisting of more than 50 locations. But NIR also expects to benefit from the deal, gaining access to the nuclear medicine market. NIR reports annual sales of more than $500 million.

The deal further strengthens Digirad's market position, especially in light of patents the company received last month that cover a method of manufacturing solid-state digital detector modules (SCAN 10/28/98). Digirad 2020 TC Imager was cleared by the Food and Drug Administration in June 1997 (SCAN 6/11/97).

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.